Impact of tranilast on restenosis after coronary angioplasty: Tranilast Restenosis Following Angioplasty Trial (TREAT)

American Heart Journal

Volumn 138, Issue 5 I, 1999, Pages 968-975

  Tamai, H ^a   Katoh, O ^a   Suzuki, S ^a   Fujii, K ^a   Aizawa, T ^a   Takase, S I ^a   Kurogane, H ^a   Nishikawa, H ^a   Sone, T ^a   Sakai, K ^a   Suzuki, T ^a  

^a SHIGA MEDICAL CENTER FOR ADULTS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYTOKINE; INTERLEUKIN 1BETA; NITRATE; PLACEBO; PLATELET DERIVED GROWTH FACTOR; TRANILAST; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG STRUCTURE; FEMALE; HUMAN; KELOID; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 0032740450     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70025-6     Document Type: Article

References (25)

1. Holmes DR, Vietstra RE, Smith HC, et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol 1984;53:77C-81C.
2. Nobuyoshi M, Kimura T, Nosaka H, et al. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol 1988;12(3):616-23.
3. Serruys PW, Luijten HE, Geuskens BR, et al. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon: a quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation 1988;77:361-71.
4. Maresta A, Balducelli M, Cantini L, et al, for the STARC Investigators. Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty: results of the randomized, double-blind STARC study. Circulation 1994;90:2710-5.
5. Eriksen UH, Amtorp O, Bagger JP, et al. Randomized double-blind Scandinavian trial of angiopeptin versus placebo for the prevention of clinical events and restenosis after coronary balloon angioplasty. Am Heart J 1995;130:1-8.
6. Tardif J-C, Cote G, Lesperance J, et al, for the multivitamins and probucol study group. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. N Engl J Med 1997;337:365-72.
7. Liu MW, Roubin GS, King SB. Restenosis after coronary angioplasty: potential biologic determinants and role of intimal hyperplasia. Circulation 1989;79:1374-87.
8. Nobuyoshi M, Kimura T, Ohishi H, et al. Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients. J Am Coll Cardiol 1991;17:433-9.
9. Ellis SG, Muller DWM. Arterial injury and the enigma of coronary restenosis. J Am Coll Cardiol 1992;19:275-7.
10. Schwartz RS, Holmes DR, Topol EJ. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol 1992;20:1284-93.
11. Ueda K, Tamai H, Hsu Y, et al. Effect of tranilast on prevention of chronic restenosis after PTCA [abstract] [in Japanese]. Jpn J Intervent Cardiol 1993;8(suppl):104.
12. Kyo E, Tamai H, Ueda K, et al. Efficacy of tranilast on prevention of restenosis after percutaneous transluminal coronary angioplasty [abstract] [in Japanese]. J Cardiol 1989;19:194.
13. Suzawa H, Kikuchi S, Ichikawa K, et al. Inhibitory action of tranilast, an anti-allergic drug, on the release of cytokines and PGE2 from human monocytes-macrophages. Jpn J Pharmacol 1992;60:85-90.
14. Suzawa H, Kikuchi S, Arai N, et al. The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts. Jpn J Pharmacol 1992;60:91-6.
15. Miyazawa K, Kikuchi S, Fukuyama J, et al. Inhibition of PDGF- and TGF-beta 1-induced collagen synthesis, migration and proliferation by tranilast in vascular smooth muscle cells from spontaneously hypertensive rats. Atherosclerosis 1995;118(2):213-21.
16. Fukuyama J, Miyazawa K, Hamano S, et al. Inhibitory effects of tranilast on proliferation, migration, and collagen synthesis of human vascular smooth muscle cells. Can J Physiol Pharmacol 1996;74(1):80-4.
17. Hishikawa K, Nakaki T, Hirahashi J, et al. Tranilast restores cytokine-induced nitric oxide production against platelet-derived growth factor in vascular smooth muscle cells. J Cardiovasc Pharmacol 1996;28(2):200-7.
18. Tanaka K, Honda M, Kuramochi T, et al. Prominent inhibitory effects of tranilast on migration and proliferation of and collagen synthesis by vascular smooth muscle cells. Atherosclerosis 1994;107:179-85.
19. Fukuyama J, Ichikawa K, Hamano S, et al. Tranilast suppresses the vascular intimal hyperplasia after balloon injury in rabbits fed on a high-cholesterol diet. Eur J Pharmacol 1996;318(2-3):327-32.
20. Strauss BH, Chisholm RJ, Keeley FW, et al. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res 1994;75:650-8.
21. Kakuta T, Currier JW, Haudenschild CC, et al. Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model. Circulation 1994;89:2809-15.
22. Post MJ, Borst C, Kuntz RE. The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty: a study in the normal rabbit and the hypercholesterolemic Yucatan micropig. Circulation 1994;89:2816-21.
23. Lafont A, Guzman LA, Whitlow PL, et al. Restenosis after experimental angioplasty: intimal, medial, and adventitial changes associated with constrictive remodeling. Circ Res 1995;76:996-1002.
24. Kosuga K, Tamai H, Ueda K, et al. Effectiveness of tranilast on restenosis after directional coronary atherectomy. Am Heart J 1997;134:712-8.
25. Hsu Y-S, Tamai H, Ueda K, et al. Efficacy of tranilast on restenosis after coronary stenting [abstract]. Circulation 1996;94(suppl I):I-620.